Halo-substituted bisindolemaleimide protein kinase C inhibitors
US5936084A · kind A · utility
24Cited by
9References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 30, 1997 |
| Grant date | Aug 10, 1999 |
| Priority date | — |
| Expiry date | Apr 30, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel halo-substituted bis-indolemaleimide compounds of the formula: ##STR1## The invention further provides a method of preparing the disclosed compounds and the preparation of pharmaceutical formulation for use in inhibiting Protein Kinase C in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.